Manchester (MANU) Stock Price & Analysis
Manchester (MANU) closed at USD 20.58 on Thursday, October 15, 2026, down 0.05% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 20.59; the Oct 15, 2026 session ranged USD 20.47–20.86 on volume of 324,257 shares. Market capitalization is $3.55B, with a 52-week range of USD 14.85–24.45 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MANU.md
Key facts (MANU)
- 1 of 80 tracked superinvestors hold MANU (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Analysts: Hold (mean 2.50 on a 1–5 scale) (2 analysts), mean target USD 23.02 (range 20.12–25.91).
- Total return with dividends: 1Y +14.7% vs S&P 500 +18.1%; 5Y +25.5% vs S&P 500 +85.1%.
- Next earnings: 2026-12-10, EPS estimate USD 0.06, revenue estimate $151M.
Superinvestors (SEC 13F-HR, Q2 2026) (MANU)
1 of 80 tracked investors hold MANU. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Leon Cooperman | Omega Family Office | 1.90% | $67.2M | Unchanged |
Analysts (MANU)
Consensus Hold (mean 2.50 on a 1–5 scale), 2 analysts; mean target USD 23.02 (low 20.12, high 25.91).
Total return (dividends reinvested) (MANU)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +14.7% | +25.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +14.8% | +4.6% |
| Volatility (annualized) | 33.6% | 40.9% |
| Max drawdown | -18.9% (Oct 2025→Dec 2025) | -51.7% (Feb 2023→Mar 2025) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 20.58 |
|---|---|
| Change | ▼ 0.05% (down) |
| Previous Close | USD 20.59 |
| Open | USD 20.66 |
| Day Range | USD 20.47 – 20.86 |
| 52-Week Range | USD 14.85 – 24.45 |
| Volume | 324,257 shares |
| Market Cap | $3.55B |
| Exchange | NYQ |
Technical Analysis (MANU)
Nexqual's technical model rates MANU "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.03 (neutral) |
| vs SMA50 | Below (USD 21.38) |
| MACD | -0.13 (negative) |
Analyst Ratings (MANU)
Wall Street analysts rate MANU "Hold" based on 2 analysts, with a mean price target of USD 23.02 (range USD 20.12–25.91), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 23.02 |
| High Target | USD 25.91 |
| Low Target | USD 20.12 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (MANU)
| Next Earnings Date | 2026-12-10 |
|---|---|
| EPS Estimate | USD 0.06 |
| Revenue Estimate | $151.00M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.16 vs est -0.3 ▲ beat |
| 2026-03-31 | USD 0.03 vs est -0.04 ▲ beat |
| 2025-12-31 | USD 0.02 vs est 0.07 ▼ miss |
| 2025-09-30 | USD -0.01 vs est 0.06 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (MANU)
| Total Revenue | $677.65M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -4.10% |
| Gross Margin | +82.55% |
| Operating Margin | -15.06% |
| Profit Margin | -6.34% |
| ROE | -24.97% |
| Debt / Equity | 4.6 |
| Current Ratio | 0.33 |
| Total Cash | $67.25M |
| Total Debt | $692.22M |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (MANU)
Nexqual rates Manchester's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Mixed — Revenue +1.7% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 83%, operating -15% |
| Balance Sheet | Critical — GBP 67M cash vs GBP 692M debt |
| Cash Flow | Solid — Operating cash flow GBP 179M (TTM) |
| Efficiency | Critical — ROE -25%, ROA -0.5% |
Ownership (MANU)
| Insider Ownership | +31.91% |
|---|---|
| Institutional Ownership | +59.45% |
| Shares Outstanding | 56.14M |
| Float | 38.23M |
| Short % of Float | +10.78% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (MANU)
Manchester is led by Omar Berrada (age 47), CEO & Director, per Nexqual as of October 16, 2026 at 05:21 UTC.
| CEO & Director | Omar Berrada (age 47) |
|---|---|
| Executive Co-Chairman | Joel M. Glazer (age 58) |
| Executive Co-Chairman | Avram A. Glazer (age 65) |
| CFO & Director | Roger Bell (age 62) |
| Chief Operating Officer | Collette Roche |
Major Backers & Investors (MANU)
Notable institutional backers of Manchester include Ariel Investments, LLC, Ariel Investment Trust-Ariel Fund, Cooperman, Leon G., according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Ariel Investments, LLC | 16.49% |
| Ariel Investment Trust-Ariel Fund | 9.07% |
| Cooperman, Leon G. | 5.22% |
| Lindsell Train Limited | 4.91% |
| Pinnacle Associates, Ltd. | 2.59% |
| Gamco Investors, Inc ET AL | 2.12% |
| Harvey Partners, LLC | 2.01% |
| Breach Inlet Capital Management, LLC | 1.97% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BATRA | Atlanta Braves Holdings, Inc. - | USD 54.66 | ▼ 5.24% |
| LION | Lionsgate Studios Corp | USD 11.02 | ▼ 0.9% |
| SPHR | Sphere Entertainment Co. | USD 108.85 | ▲ 6.24% |
| VSNT | Versant Media Group, Inc. | USD 31.24 | ▲ 0.58% |
| IMAX | Imax Corporation | USD 51.55 | ▼ 0.21% |
| CNK | Cinemark Holdings Inc Cinemark | USD 38.52 | ▲ 1.53% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt